Tricyclodecan-9-yl-Xanthogenate (D609) mechanism of actions: A mini-review of literature

Neurochemical Research

Volumn 37, Issue 4, 2012, Pages 671-679

  Adibhatla, Rao Muralikrishna ^a,b,c,d   Hatcher, J F ^a   Gusain, A ^a  

^a University of Wisconsin Health   (United States)

^b University of Wisconsin Cardiovascular Research Center   (United States)

^c UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^d WILLIAM S MIDDLETON MEMORIAL VETERANS HOSPITAL   (United States)

Author keywords

Antioxidant; Cell cycle; Ceramide; Cytokines; Glutathione; Inflammation; Microglia macrophage; PC PLC; Phosphatidylcholine; Phospholipase C; Proliferation; Reactive oxygen species; Sphingomyelin synthase; Stroke

Indexed keywords

AMYLOID BETA PROTEIN; CERAMIDE; DIACYLGLYCEROL; ENZYME INHIBITOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; FIBROBLAST GROWTH FACTOR 2; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; LMV 601; PHOSPHOLIPASE C; PHOSPHOLIPASE D; SPHINGOLIPID; SPHINGOMYELIN PHOSPHODIESTERASE; SPHINGOMYELIN SYNTHASE; SYNTHETASE; TRICYCLO[4.3.0.1]DECAN 9 YL XANTHOGENATE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ZINC ION;

ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; ANTIVIRAL ACTIVITY; ATHEROSCLEROTIC PLAQUE; BRAIN INFARCTION; CELL CYCLE ARREST; CELL DIFFERENTIATION; CELL PROLIFERATION; CHELATION; CYTOKINE PRODUCTION; DOWN REGULATION; DRUG MECHANISM; DRUG STRUCTURE; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LIPID METABOLISM; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; REVIEW; STROKE; STRUCTURE ACTIVITY RELATION;

ANIMALS; ANTIOXIDANTS; BRIDGED COMPOUNDS; CELL CYCLE; CENTRAL NERVOUS SYSTEM DISEASES; HUMANS; SPHINGOMYELIN PHOSPHODIESTERASE; THIONES; TYPE C PHOSPHOLIPASES;

BACTERIA (MICROORGANISMS); MAMMALIA;

EID: 84862906027     PISSN: 03643190     EISSN: 15736903     Source Type: Journal    
DOI: 10.1007/s11064-011-0659-z     Document Type: Review

References (97)

1. Sauer G, Amtmann E, Melber K et al (1984) DNA and RNA virus species are inhibited by xanthates, a class of antiviral compounds with unique properties. Proc Natl Acad Sci 81:3263-3267 (Pubitemid 14123418)
2. Muller-Decker K (1989) Interruption of TPA-induced signals by an antiviral and antitumoral xanthate compound: inhibition of a phospholipase C-type reaction. Biochem Biophys Res Commun 162:198-205 (Pubitemid 19185846)
3. Amtmann E (1996) The antiviral, antitumoural xanthate D609 is a competitive inhibitor of phosphatidylcholine-specific phospholipase C. Drugs Exp Clin Res 22:287-294 (Pubitemid 27060176)
4. Amtmann E, Mayer FK, Pink H, et al (2010) LMV-601: effect on HPV-16 and HPV-18 infected human cervical carcinoma cells. 50th interscience conference on antimicrobial agents and chemotherapy (ICAAC 2010), Boston
5. Clark MA, Shorr RG, Bomalaski JS (1986) Antibodies prepared to Bacillus cereus phospholipase C crossreact with a phosphatidylcholine preferring phospholipase C in mammalian cells. Biochem Biophys Res Commun 140:114-119
6. Wang N, Du CQ, Wang SS et al (2004) D609 induces vascular endothelial cells and marrow stromal cells differentiation into neuron-like cells. Acta Pharmacol Sin 25:442-446 (Pubitemid 38470412)
7. Wang N, Lv X, Su L et al (2006) D609 blocks cell survival and induces apoptosis in neural stem cells. Bioorg Med Chem Lett 16:4780-4783 (Pubitemid 44175864)
8. Wang N, Xie K, Huo S et al (2007) Suppressing phosphatidylcholine- specific phospholipase C and elevating ROS level, NADPH oxidase activity and Rb level induced neuronal differentiation in mesenchymal stem cells. J Cell Biochem 100: 1548-1557 (Pubitemid 46515586)
9. Wang N, Sun C, Huo S et al (2008) Cooperation of phosphatidylcholine- specific phospholipase C and basic fibroblast growth factor in the neural differentiation of mesenchymal stem cells in vitro. Int J Biochem Cell Biol 40:294-306 (Pubitemid 350137881)
10. Cheng Y, Zhao Q, Liu X et al (2006) Phosphatidylcholine-specific phospholipase C, p53 and ROS in the association of apoptosis and senescence in vascular endothelial cells. FEBS Lett 580:4911-4915 (Pubitemid 44286854)
11. Liu X, Yin D, Zhang Y et al (2007) Vascular endothelial cell senescence mediated by integrin b4 in vitro. FEBS Lett 581: 5337-5342 (Pubitemid 350101510)
12. Zhao J, Miao J, Zhao B et al (2005) Upregulating of Fas, integrin β4 and P53 and depressing of PC-PLC activity and ROS level in VEC apoptosis by safrole oxide. FEBS Lett 579:5809-5813 (Pubitemid 41455668)
13. Cdc20-mediated ubiquitin-proteasome pathway. J Cell Biochem 107:686-696
14. Paris L, Cecchetti S, Spadaro F et al (2010) Inhibition of phosphatidylcholine-specific phospholipase C downregulates HER2 overexpression on plasma membrane of breast cancer cells. Breast Cancer Res 12:R27
15. Iorio E, Ricci A, Bagnoli M et al (2010) Activation of phosphatidylcholine cycle enzymes in human epithelial ovarian cancer cells. Cancer Res 70:2126-2135
16. Cecchetti S, Spadaro F, Lugini L et al (2007) Functional role of phosphatidylcholine-specific phospholipase C in regulating CD16 membrane expression in natural killer cells. Eur J Immunol 37: 2912-2922 (Pubitemid 47578310)
17. Chen C, Hu Q, Yan J et al (2007) Multiple effects of 2ME2 and D609 on the cortical expression of HIF-1α and apoptotic genes in a middle cerebral artery occlusion induced focal ischemia rat model. J Neurochem 102:1831-1841 (Pubitemid 47329256)
18. Monick MM, Carter AB, Gudmundsson G et al (1999) A phosphatidylcholine- specific phospholipase C regulates activation of p42/44 mitogen-activated protein kinases in lipopolysaccharide-stimulated human alveolar macrophages. J Immunol 162: 3005-3012 (Pubitemid 29309330)
19. Monick MM, Mallampalli RK, Carter AB et al (2001) Ceramide regulates lipopolysaccharide-induced phosphatidylinositol 3-kinase and Akt activity in human alveolar macrophages. J Immunol 167: 5977-5985 (Pubitemid 33062795)
20. Zhang F, Zhao G, Dong Z (2001) Phosphatidylcholine-specific phospholipase C and D in stimulation of RAW264.7 mouse macrophage-like cells by lipopolysaccharide. Intl Immunopharmacol 1:1375-1384 (Pubitemid 32522989)
21. Machleidt T, Kramer B, Adam D et al (1996) Function of the p55 TNF receptor "death domain" mediated by phosphatidylcholinespecific PLC. J Exp Med 184:725-733 (Pubitemid 26324126)
22. Li YH, Maher P, Schubert D (1998) Phosphatidylcholine-specific phospholipase C regulates glutamate-induced nerve cell death. Proc Natl Acad Sci 95:7748-7753
23. Singh ATK, Radeff JM, Kunnel JG et al (2000) Phosphatidylcholine-specific phospholipase C inhibitor, tricyclodecan-9-yl xanthogenate (D609), increases phospholipase D-mediated phosphatidylcholine hydrolysis in UMR-106 osteoblastic osteosarcoma cells. Biochim Biophys Acta 1487:201-208
24. Zhang L, Zhao J, Su L et al (2010) D609 inhibits progression of preexisting atheroma and promotes lesion stability in apolipoprotein E-/-mice. A role of phosphatidylcholine-specific phospholipase in atherosclerosis. Arterioscler Thromb Vasc Biol 30: 411-418
25. Larsen EC, Hatcher JF, Adibhatla RM (2007) Effect of tricyclodecan-9-yl potassium xanthate (D609) on phospholipid metabolism and cell death during oxygen-glucose deprivation in PC12 cells. Neuroscience 146:946-961 (Pubitemid 46711143)
26. Yu ZF, Nikolova-Karakashian M, Zhou DH et al (2000) Pivotal role for acidic sphingomyelinase in cerebral ischemia-induced ceramide and cytokine production, and neuronal apoptosis. J Mol Neurosci 15:85-97 (Pubitemid 32108678)
27. Gonzalez-Bulnes P, Gonzalez-Roura A, Canals D et al (2010) 2-aminohydroxamic acid derivatives as inhibitors of Bacillus cereus phosphatidylcholine preferred phospholipase C PC-PLCBc. Bioorg Med Chem 18:8549-8555
28. Gonzalez-Roura A, Casas J, Llebaria A (2002) Synthesis and phospholipase C inhibitory activity of D609 diastereomers. Lipids 37:401-406 (Pubitemid 34441803)
29. Tafesse FG, Ternes P, Holthuis JCM (2006) The multigenic sphingomyelin synthase family. J Biol Chem 281:29421-29425 (Pubitemid 44536948)
30. Huitema K, van den Dikkenberg J, Brouwers JFHM et al (2004) Identification of a family of animal sphingomyelin synthases. EMBO J 23:33-44 (Pubitemid 38165745)
31. Luberto C, Hannun YA (1998) SM synthase, a potential regulator of intracellular levels of ceramide and diacylglycerol during SV40 transformation. Does SM synthase account for the putative PC-specific PLC? J Biol Chem 273:14550-14559 (Pubitemid 28319178)
32. Luberto C, Yoo DS, Suidan HS et al (2000) Differential effects of sphingomyelin hydrolysis and resynthesis on the activation of NF-kappa B in normal and SV40-transformed human fibroblasts. J Biol Chem 275:14760-14766 (Pubitemid 30339770)
33. Perry RJ, Ridgway ND (2004) The role of de novo ceramide synthesis in the mechanism of action of the tricyclic xanthate D609. J Lipid Res 45:164-173 (Pubitemid 38176627)
34. Adibhatla RM, Hatcher JF (2010) Protection by D609 through cell-cycle regulation after stroke. Mol Neurobiol 41:206-217
35. Dirkx E, Schwenk RW, Glatz JF et al (2011) High fat diet induced diabetic cardiomyopathy. Prostaglandins Leukot Essent Fatty Acids 85:219-225
36. Irie F, Hirabayashi Y (1998) Application of exogenous ceramide to cultured rat spinal motoneurons promotes survival or death by regulation of apoptosis depending on its concentrations. J Neurosci Res 54:475-485 (Pubitemid 28507026)
37. Luberto C, Kraveka JM, Hannun YA (2002) Ceramide regulation of apoptosis versus differentiation: a walk on a fine line. Lessons from neurobiology. Neurochem Res 27:609-617
38. Riboni L, Viani P, Bassi R et al (2001) Basic fibroblast growth factor-induced proliferation of primary astrocytes. Evidence for the involvement of sphingomyelin biosynthesis. J Biol Chem 276:12797-12804
39. Ogretmen B, Hannun YA (2004) Biologically active sphingolipids in cancer pathogenesis and treatment. Nat Rev Cancer 4:604-616 (Pubitemid 39025055)
40. CIP1 by c-Myc in overcoming transforming growth factor b-induced cell-cycle arrest. Proc Natl Acad Sci 97: 9498-9503 (Pubitemid 30650804)
41. Kip1 to facilitate the activation of Cdk4/6 and early G1 phase progression. J Biol Chem 277:31263-31269 (Pubitemid 34970835)
42. Lee JY, Bielawska AE, Obeid LM (2000) Regulation of cyclindependent kinase 2 activity by ceramide. Exp Cell Res 261: 303-311 (Pubitemid 32010227)
43. Arnold HK, Sears RC (2006) Protein phosphatase 2A regulatory subunit B56α associates with c-myc and negatively regulates c-myc accumulation. Mol Cell Biol 26:2832-2844
44. Mufson RA, Gubina E, Rinaudo M et al (1998) A phosphatidylcholine phospholipase C inhibitor, D609, blocks interleukin-3 (IL-3)-induced bcl-2 expression but not c-myc expression in human IL-3-dependent cells. Exp Cell Res 240:228-235 (Pubitemid 28371103)
45. Sultana R, Newman S, Mohmmad-Abdul H et al (2004) Protective effect of the xanthate, D609, on Alzheimer's amyloid betapeptide (1-42)-induced oxidative stress in primary neuronal cells. Free Radic Res 38:449-458 (Pubitemid 38618366)
46. Sultana R, Newman SF, Abdul HM et al (2006) Protective effect of D609 against amyloid-β 1-42 induced oxidative modification of neuronal proteins: redox proteomics study. J Neurosci Res 84: 409-417 (Pubitemid 44126293)
47. Zhou DH, Lauderback CM, Yu T et al (2001) D609 inhibits ionizing radiation-induced oxidative damage by acting as a potent antioxidant. J Pharmacol Exp Ther 298:103-109 (Pubitemid 32574515)
48. Perluigi M, Joshi G, Sultana R et al (2006) In vivo protection by the xanthate tricyclodecan-9-yl-xanthogenate against amyloid β-peptide (1-42)-induced oxidative stress. Neuroscience 138: 1161-1170 (Pubitemid 43363534)
49. Bai A, Meier GP, Wang Y et al (2004) Prodrug modification increases potassium tricyclo[5.2.1.0(2,6)]-decan-8-yl dithiocarbonate (D609) chemical stability and cytotoxicity against U937 leukemia cells. J Pharmacol Exp Ther 309:1051-1059 (Pubitemid 38669691)
50. Adibhatla RM, Hatcher JF (2010) Lipid oxidation and peroxidation in CNS health and disease: from molecular mechanisms to therapeutic opportunities. Antioxid Redox Signal 12:125-169
51. Ng MNP, Kitos TE, Cornell RB (2004) Contribution of lipid second messengers to the regulation of phosphatidylcholine synthesis during cell cycle re-entry. Biochim Biophys Acta 1686: 85-99 (Pubitemid 39446881)
52. Antony P, Farooqui AA, Horrocks LA et al (2001) Effect of D609 on phosphatidylcholine metabolism in the nuclei of LA-N-1 neuroblastoma cells: a key role for diacylglycerol. FEBS Lett 509:115-118 (Pubitemid 33153092)
53. 2. Mol Cells 26:481-485
54. Wiegmann K, Schutze S, Machleidt T et al (1994) Functional dichotomy of neutral and acidic sphingomyelinases in TNF-α signaling. Cell 78:1005-1015 (Pubitemid 24292328)
55. Adibhatla RM, Hatcher JF (2008) Integration of cytokine biology and lipid metabolism in stroke. Front Biosci 13:1250-1270 (Pubitemid 351594709)
56. Kalluri HSG, Dempsey RJ (2010) D609 inhibits the proliferation of neural progenitor cells. Neuroreport 21:700-703
57. Lambertsen KL, Meldgaard M, Ladeby R et al (2005) A quantitative study of microglial-macrophage synthesis of tumor necrosis factor during acute and late focal cerebral ischemia in mice. J Cereb Blood Flow Metab 25:119-135 (Pubitemid 40096903)
58. Herrup K, Neve R, Ackerman SL et al (2004) Divide and die: cell cycle events as triggers of nerve cell death. J Neurosci 24:9232-9239 (Pubitemid 39426158)
59. Herrup K, Yang Y (2007) Cell cycle regulation in the postmitotic neuron: oxymoron or new biology? Nat Rev Neurosci 8:368-378 (Pubitemid 46652467)
60. Katchanov J, Harms C, Gertz K et al (2001) Mild cerebral ischemia induces loss of cyclin-dependent kinase inhibitors and activation of cell cycle machinery before delayed neuronal cell death. J Neurosci 21:5045-5053 (Pubitemid 32622930)
61. Osuga H, Osuga S, Wang F et al (2000) Cyclin-dependent kinases as a therapeutic target for stroke. Proc Natl Acad Sci 97:10254-10259
62. Rashidian J, Iyirhiaro GO, Park DS (2007) Cell cycle machinery and stroke. Biochim Biophys Acta 1772:484-493 (Pubitemid 46400387)
63. Wang W, Bu B, Xie M et al (2009) Neural cell cycle dysregulation and central nervous system diseases. Prog Neurobiol 89: 1-17
64. Yang Y, Herrup K (2007) Cell division in the CNS: protective response or lethal event in post-mitotic neurons? Biochim Biophys Acta 1772:457-466 (Pubitemid 46420409)
65. Khandelwal PJ, Herman AM, Moussa CE (2011) Inflammation in the early stages of neurodegenerative pathology. J Neuroimmunol 238:1-11
66. Graeber MB, Li W, Rodriguez ML (2011) Role of microglia in CNS inflammation. FEBS Lett (in press)
67. Lalancette-Hebert M, Gowing G, Simard A et al (2007) Selective ablation of proliferating microglial cells exacerbates ischemic injury in the brain. J Neurosci 27:2596-2605 (Pubitemid 46393607)
68. Madinier A, Bertrand N, Mossiat C et al (2009) Microglial involvement in neuroplastic changes following focal brain ischemia in rats. PLoS ONE 4:e8101
69. Monk PN, Shaw PJ (2006) ALS: life and death in a bad neighborhood. Nat Med 12:885-887 (Pubitemid 44175136)
70. Ekdahl CT, Kokaia Z, Lindvall O (2009) Brain inflammation and adult neurogenesis: the dual role of microglia. Neuroscience 158:1021-1029
71. Schutze S, Potthoff K, Machleidt T et al (1992) TNF activates NF-κB by phosphatidylcholine-specific phospholipase C-induced 'acidic' sphingomyelin breakdown. Cell 71:765-776
72. Lv X, Su L, Yin D et al (2008) Knockdown of integrin [beta]4 in primary cultured mouse neurons blocks survival and induces apoptosis by elevating NADPH oxidase activity and reactive oxygen species level. Int J Biochem Cell Biol 40:689-699 (Pubitemid 351288588)
73. Lv X, Wang N, Su L et al (2006) Inhibition of PC-PLC blocked the survival of mouse neural cells by up-regulating the expression of integrin beta4 and Rb. Dev Neurosci 28:499-504 (Pubitemid 44532977)
74. Zhao J, Zhao B, Wang W et al (2007) Phosphatidylcholinespecific phospholipase C and ROS were involved in chicken blastodisc differentiation to vascular endothelial cells. J Cell Biochem 102:421-428 (Pubitemid 47519415)
75. Zhang L, Li H, Li H et al (2011) Lipopolysaccharide activated phosphatidylcholine-specific phospholipase C and induced IL-8 and MCP-1 production in vascular endothelial cells. J Cell Physiol 226:1694-1701
76. Fantuzzi L, Spadaro F, Purificato C et al (2008) Phosphatidylcholine- specific phospholipase C activation is required for CCR5-dependent, NF-kB-driven CCL2 secretion elicited in response to HIV-1 gp120 in human primary macrophages. Blood 111:3355-3363
77. Ramoni C, Spadaro F, Menegon M et al (2001) Cellular localization and functional role of phosphatidylcholine-specific phospholipase C in NK cells. J Immunol 167:2642-2650 (Pubitemid 32768893)
78. Ramoni C, Spadaro F, Barletta B et al (2004) Phosphatidylcholine-specific phospholipase C in mitogen-stimulated fibroblasts. Exp Cell Res 299:370-382 (Pubitemid 39179804)
79. Spadaro F, Ramoni C, Mezzanzanica D et al (2008) Phosphatidylcholine- specific phospholipase C activation in epithelial ovarian cancer cells. Cancer Res 68:6541-6549
80. Tzeng J-I, Chen B-C, Chang H-M et al (2010) Involvement of phosphatidylcholine-phospholipase C and protein kinase C in peptidoglycan- induced nuclear factor-[kappa]B activation and cyclooxygenase-2 expression in RAW 264.7 macrophages. Pharmacol Res 61:162-166
81. Heller RA, Kronke M (1994) TNF receptor-mediated signaling pathways. J Cell Biol 126:5-9
82. Schutze S, Berkovic D, Tomsing O et al (1991) TNF-α induces rapid production of 1',2'-diacylglycerol by a phosphatidylcholine-specific PLC. J Exp Med 174:975-988
83. Schutze S, Machleidt T, Kronke M (1994) The role of diacylglycerol and ceramide in TNF-α and IL-1 signal transduction. J Leukoc Biol 56:533-541 (Pubitemid 24348808)
84. Meng A, Luberto C, Meier P et al (2004) Sphingomyelin synthase as a potential target for D609-induced apoptosis in U937 human monocytic leukemia cells. Exp Cell Res 292:385-392 (Pubitemid 38018853)
85. Li Z, Hailemariam TK, Zhou H et al (2007) Inhibition of sphingomyelin synthase (SMS) affects intracellular sphingomyelin accumulation and plasma membrane lipid organization. Biochim Biophys Acta 1771:1186-1194 (Pubitemid 47404966)
86. Lee W-K, Torchalski B, Thevenod F (2007) Cadmium-induced ceramide formation triggers calpain-dependent apoptosis in cultured kidney proximal tubule cells. Am J Physiol-Cell Physiol 293:C839-C847 (Pubitemid 47437392)
87. Lee WK, Torchalski B, Kohistani N et al (2011) ABCB1 protects kidney proximal tubule cells against cadmium-induced apoptosis: roles of cadmium and ceramide transport. Toxicol Sci 121:343-356
88. Li H, Zhang L, Yin D et al (2010) Targeting phosphatidylcholinespecific phospholipase C for atherogenesis therapy. Trends Cardiovasc Med 20:172-176
89. Zhou D, Lauderback CM, Yu T et al (2001) D609 inhibits ionizing radiation-induced oxidative damage by acting as a potent antioxidant. J Pharmacol Exp Ther 298:103-109 (Pubitemid 32574515)
90. Ansari MA, Joshi G, Huang Q et al (2006) In vivo administration of D609 leads to protection of subsequently isolated gerbil brain mitochondria subjected to in vitro oxidative stress induced by amyloid beta-peptide and other oxidative stressors: relevance to Alzheimer's disease and other oxidative stress-related neurodegenerative disorders. Free Radic Biol Med 41:1694-1703 (Pubitemid 44634240)
91. Opii WO, Sultana R, Abdul HM et al (2007) Oxidative stress and toxicity induced by the nucleoside reverse transcriptase inhibitor (NRTI)-2', 3'-dideoxycytidine (ddC): relevance to HIV-dementia. Exp Neurol 204:29-38 (Pubitemid 46330254)
92. 2 or 2, 2-azobis-(2-amidinopropane) dihydrochloride by the glutathione mimetic tricyclodecan-9-yl-xanthogenate. Free Radic Biol Med 38:1023-1031 (Pubitemid 40386548)
93. Abdul HM, Butterfield DA (2005) Protection against amyloid β-peptide (1-42)-induced loss of phospholipid asymmetry in synaptosomal membranes by tricyclodecan-9-xanthogenate (D609) and ferulic acid ethyl ester: implications for Alzheimer's disease. Biochim Biophys Acta 1741:140-148 (Pubitemid 40824999)
94. Lauderback CM, Drake J, Zhou D et al (2003) Derivatives of xanthic acid are novel antioxidants: application to synaptosomes. Free Radic Res 37:355-365 (Pubitemid 36240398)
95. Giron-Calle J, Srivatsa K, Forman HJ (2002) Priming of alveolar macrophage respiratory burst by H2O2 is prevented by phosphatidylcholine- specific phospholipase C inhibitor tricyclodecan9-yl-xanthate (D609). J Pharmacol Exp Ther 301:87-94 (Pubitemid 34250283)
96. Kiss Z, Tomono M (1995) Compound D609 inhibits phorbol ester-stimulated phospholipase D activity and phospholipase C-mediated phosphatidylethanolamine hydrolysis. Biochim Biophys Acta 1259:105-108
97. Su H-C, Ma C-T, Lin C-F et al (2011) The acid sphingomyelinase inhibitors block interferon-[alpha]-induced serotonin uptake via a COX-2/Akt/ERK/STAT- dependent pathway in T cells. Int Immunopharmacol 11:1823-1831